Home » Topics » BioWorld Science

BioWorld Science
RSS

Medshine Discovery presents Rho kinase inhibitors

Feb. 4, 2019

Nerviano Medical Sciences synthesizes choline kinase inhibitors

Feb. 4, 2019

Roche and Genentech identify RIP-1 inhibitors

Feb. 4, 2019

Oxford University signs option agreement with Blue Water Vaccines for universal influenza vaccine

Feb. 4, 2019

Dart NeuroScience discloses PDE7B inhibitors

Feb. 4, 2019

GenSight announces 48-week data from RESCUE trial of GS-010 in LHON

Feb. 4, 2019

FDA issues complete response letter for ALKS-5461 NDA for adjunctive treatment of MDD

Feb. 4, 2019

CSIC patents new PDE8A inhibitors

Feb. 4, 2019

Tripartite motif family-like 2 downregulation reduces oral squamous cell carcinoma growth

Feb. 4, 2019

Preclinical data presented on PBK-001 vaccine for the treatment of melioidosis

Feb. 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...